JUN and neoplasm: Regarding the AP-1 transcription factor, our previous study demonstrated that two components of the AP-1 complex associated with tumor progression, namely Fos-related antigen 1 (FRA-1) and phospho-cJun, exhibited a time-dependent expression pattern following HPF administration.